Search

Your search keyword '"Carreira, Patricia E"' showing total 355 results

Search Constraints

Start Over You searched for: Author "Carreira, Patricia E" Remove constraint Author: "Carreira, Patricia E"
355 results on '"Carreira, Patricia E"'

Search Results

1. Similarities and differences between systemic juvenile idiopathic arthritis and adult-onset Still’s disease: a multicenter Spanish study

2. Subcutaneous vs intravenous abatacept in rheumatoid arthritis-interstitial lung disease. National multicentre study of 397 patients

3. Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis

4. Does the Impact of COVID‐19 on Patients With Systemic Sclerosis Change Over Time?

5. Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research

6. DLco and echocardiographic parameters in identifying mild pulmonary hypertension in the EUSTAR cohort of systemic sclerosis patients

7. Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort

8. Recommendations for prevention of infection in systemic autoimmune rheumatic diseases

9. Recomendaciones SER sobre prevención de infección en enfermedades reumáticas autoinmunes sistémicas

11. Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis

12. Does the impact of COVID-19 on patients with systemic sclerosis change over time?

13. The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements

15. Clinical Characteristics of Juvenile Idiopathic Inflammatory Myopathy and Comparison With Adult Patients: Analysis From a Multicentric Cohort in Spain

17. Does the impact of COVID‐19 on patients with systemic sclerosis change over time?

18. Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database

19. ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products

20. Late Skin Fibrosis in Systemic Sclerosis: A Study from the EUSTAR Cohort

21. Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort

22. Mortality and prognostic factors in idiopathic inflammatory myositis: a retrospective analysis of a large multicenter cohort of Spain

24. Clinical characteristics of juvenile onset systemic sclerosis patients from the juvenile scleroderma inception cohort compared to adult age juvenile-onset patients from EUSTAR. Are these differences suggesting risk for mortality?

25. Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria

26. Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis

27. Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database.

28. Late skin fibrosis in systemic sclerosis: a study from the EUSTAR cohort.

29. Retrotransposon instability dominates the acquired mutation landscape of mouse induced pluripotent stem cells

30. Inmune-mediated inflammatory rheumatic diseases in transgender people: A scoping review

31. Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database

32. Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database

34. Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire

35. Digital ulcers predict a worse disease course in patients with systemic sclerosis

36. A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study

37. Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study

38. Impact and outcome of COVID-19 on SSc-ILD

40. Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research

41. Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population

42. Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database

45. Additional file 2 of TBP and SNAP50 transcription factors bind specifically to the Pr77 promoter sequence from trypanosomatid non-LTR retrotransposons

46. Additional file 1 of TBP and SNAP50 transcription factors bind specifically to the Pr77 promoter sequence from trypanosomatid non-LTR retrotransposons

47. The burden of systemic sclerosis in Switzerland - the Swiss systemic sclerosis EUSTAR cohort

50. Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials

Catalog

Books, media, physical & digital resources